Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

AKBA Q1 2016 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

Q1 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20M

Operating Income

-$26M

Net Income

-$26M

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$221M

Total Liabilities

$54M

Stockholders' Equity

$168M

Cash & Equivalents

$43M

← FY 2016 All Quarters Q2 2016 →